Comparing the efficacy of continuous erythropoietin receptor activator and darbepoetin Alfa treatments in Japanese patients with chronic kidney disease during the predialysis period: A propensity‐matched analysis

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|20|S4|22-28

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.S4, 2015-12, pp. : 22-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Subcutaneous injection pain with C.E.R.A., a continuous erythropoietin receptor activator, compared with darbepoetin alfa

By Pannier Anne   Jordan Paul   Dougherty Frank C.   Bour Fabrice   Reigner Bruno  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 3025-3032

Informa Healthcare

Access to resources Recommend Favorite

A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease

By Roger Simon D.   Suranyi Michael G.   Walker Rowan G.    

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2181-2187

Informa Healthcare

Access to resources Recommend Favorite

The relative dosing of epoetin alfa and darbepoetin alfa in chronic kidney disease

By Cremieux Pierre-Yves   Van Audenrode Marc   Lefebvre Patrick  

Current Medical Research and Opinion, Vol. 22, Iss. 12, 2006-12 ,pp. : 2329-2336

Informa Healthcare

Access to resources Recommend Favorite

Preference for monthly darbepoetin alfa dosing in patients with chronic kidney disease not receiving dialysis

By Hoggard Jeffrey   Crouch Thomas   McMurray Stephen   Levine Michael   Prathikanti Radha   Scarlata Debra   Audhya Paul  

Current Medical Research and Opinion, Vol. 22, Iss. 10, 2006-10 ,pp. : 2023-2030

Informa Healthcare

Access to resources Recommend Favorite

Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agents*

By Silver M. R.   Geronemus R.   Krause M.   Chen C. Y.   Kewalramani R.   Stehman-Breen C.  

Current Medical Research and Opinion, Vol. 25, Iss. 1, 2009-01 ,pp. : 123-131

Informa Healthcare

Access to resources Recommend Favorite